The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Canaan Partners X Llc since year 2005.
The trader's CIK number is 1673228.
At the time of this reporting, Canaan Partners X Llc is the 10% Owner of Protagonist Therapeutics, Inc .
(stock ticker symbol PTGX).
See this page for all insider trading activities at Protagonist Therapeutics, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-23||PTGX||Protagonist Therapeutics, Inc||Sale||59,950||20.71||1,241,324|
|2018-03-22||PTGX||Protagonist Therapeutics, Inc||Sale||4,759||20.62||98,135|
|2018-03-20||PTGX||Protagonist Therapeutics, Inc||Sale||17,060||20.61||351,538|
|2018-03-21||PTGX||Protagonist Therapeutics, Inc||Sale||17,699||20.61||364,723|
|2018-03-16||PTGX||Protagonist Therapeutics, Inc||Sale||6,926||20.51||142,066|
|2018-03-19||PTGX||Protagonist Therapeutics, Inc||Sale||13,439||20.57||276,440|
|2018-03-13||PTGX||Protagonist Therapeutics, Inc||Sale||1,204||20.84||25,093|
|2018-03-14||PTGX||Protagonist Therapeutics, Inc||Sale||200||20.77||4,154|
|2018-03-15||PTGX||Protagonist Therapeutics, Inc||Sale||11,751||20.64||242,517|
|2016-08-16||PTGX||Protagonist Therapeutics, Inc||Buy||583,333||12.00||6,999,996|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Canaan Partners X Llc (10% Owner of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.